One thing Cortex has in the newer molecules is the capability to extend patent life egregiously-plus high impacts in Neurodegenerative, plus the possibility to hit Sleep Apnea and the likelihood of an ADHD deal with either ADHD Europe CX-717 or 717-1739 OR CX-1739 here in the USA. What if SGP see's something in DP or ADHD? The upside is enormous from this price. The key is a decent deal, IN 2008....Pharma's have to take shots.